Trump's policies, including tariffs and onshoring, are being discussed in the context of their potential benefits for AI stocks, with specific attention paid to Moderna's performance and guidance.
5 reports, 2 independent
Updated Jul 16
Gone quiet
- Reports
- 5
- Developments
- 4
- Repetition
- 20%
New informationRepeats or wire copies
AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.
What happened
Trump's policies, including tariffs and onshoring, are being discussed in the context of their potential benefits for AI stocks, with specific attention paid to Moderna's performance and guidance.
Who's involved
What this event is mainly aboutHow it developed
Newest first. Tap a step to see who reported it.Trump tariffs, onshoring trends, and their impact on AI stocks, including Moderna, are discussed alongside Jim Cramer's views.1 source
- Meli is cited as a beneficiary of Trump-era tariffs benefiting AI stocks.
- The Bank of New York Mellon is noted as a beneficiary of Trump-era tariffs benefiting AI stocks.
- Vici Properties is cited as a beneficiary of Trump-era tariffs on AI stocks.
Keep exploring
The entities involved
-
Moderna
American biotechnology company
-
Donald Trump
American businessman and politician (born 1946), President of the United States (2017–2021; since 2025)
-
Jim Cramer
American stockbroker, television personality, author
-
The Bank of New York Mellon
American investment banking services holding company
Nothing else this week.
Related events
Coverage
Newest first; wire copies grouped- 247wallst.com
- Insider MonkeyModerna, Inc. (MRNA)’s “Got The Double Whammy,” Says Jim Cramer We recently published 10 Stocks Jim Cramer Mentioned As He Talked About “Love Lost” Between Microsoft & OpenAI. Moderna, Inc. (NASDAQ:M
- Unknown outlet
- Unknown outlet
- Unknown outlet